Source: http://grants2.nih.gov/grants/guide/pa-files/PAR-10-272.html
Timestamp: 2014-03-12 00:52:54
Document Index: 169159509

Matched Legal Cases: ['art 52', 'arts 74', 'art 46', 'art\n46', 'art 93', 'art 87', '§ 1320', 'art 1003']

PAR-10-272: NIOSH Support for Conferences and Scientific Meetings (R13)
of Health and Human Services (HHS)
(CDC), (http://www.cdc.gov) Components of Participating Organizations
National Institute for Occupational Safety and Health (NIOSH), (http://www.cdc.gov/niosh/) Title: NIOSH Support for Conferences and Scientific
Meetings (R13)
The policies, guidelines, terms, and
conditions of the HHS Centers for Disease Control and Prevention (CDC) stated
in this announcement may differ from those used by the HHS National Institutes
of Health (NIH). Authority
This program is described in the Catalog of
Federal Domestic Assistance at http://www.cfda.gov/ and is not
or Health Systems Agency Review. Awards are made under the authorization of the
Occupational Safety and Health Act of 1970, Section
20(a) and 21(a) (29 USC 669(a) and 29 USC 670); Federal Mine Safety and Health
Act, Section 501(a), 30 USC 951(a); Section 301 of the Public Health Service
Act as amended (42 USC 241) and under Federal Regulations 42 CFR Part 52 and 45
CFR Parts 74 and 92. All awards are subject to the terms and conditions, cost
Statement. Announcement
Type Reissue of PAR-08-072.
Announcement (PA) Number: PAR-10-272
Federal assistance must be submitted electronically through Grants.gov (http://www.grants.gov) using the SF424 Research and Related
(R&R) forms and the SF424 (R&R) Application Guide. APPLICATIONS MAY NOT
BE SUBMITTED IN PAPER FORMAT. This FOA must be read in
conjunction with the application guidelines included with this announcement in Grants.gov/Apply for Grants (hereafter called Grants.gov/Apply).
93.262 Key Dates
Release/Posted Date: August 25, 2010
Opening Date: September 25, 2010 (Earliest
date an application may be submitted to Grants.gov) Letter of Intent
Receipt Date: Sixty calendar days in advance of standard Application
institution/organization). Application Due Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm Peer Review
Anticipated Start Date(s): Standard dates
apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward Additional
Information To Be Available Date (URL Activation Date): Not Applicable Expiration Date: January
8, 2013 Due Date
The National Institute for Occupational Safety
and Health (NIOSH) within the Centers for Disease Control and Prevention (CDC)
invites grant applications for conferences and scientific meetings related to occupational
Purpose: The purpose of the NIOSH Research Conference Grant Program (R13) is
to support high quality conferences/scientific meetings that are relevant
to its scientific mission and to the public health. A
conference/scientific meeting is defined as a gathering, symposium, seminar,
scientific meeting, workshop or any other organized, formal meeting where
persons assemble to coordinate, exchange, and disseminate information or
to explore or clarify a defined subject, problem, or area of knowledge. Applications for training only events will not be considered under
Support: This funding opportunity announcement (FOA) will use
the HHS conference grant (R13) award mechanism. Funds Available and
Anticipated Number of Awards: Awards issued under this FOA are contingent upon the
meritorious applications. Budget and Project Period: The total amount
awarded is expected to range between $10,000 and $20,000.
Requests for more than $20,000 (total costs) will require a prior approval letter from CDC/NIOSH.
Project periods can range between one and three years. Facilities and administrative (F&A) costs (also called indirect
costs) and pre-award costs are not allowable costs for this mechanism.
Research Strategy Length: The R13 application
Research Strategy section may not exceed 6 pages, including tables, graphs,
figures, diagrams, and charts. See Table of Page Limits. Eligible Institutions/Organizations: Institutions/organizations
III, 1.A. are eligible to apply. Eligible Project
Directors/Principal Investigators (PDs/PIs). Individuals with the skills, knowledge, and resources necessary to
carry out the proposed research are invited to work with their
institution/organization to develop an application for support.
individuals with disabilities are always encouraged to apply for NIOSH support. Number of PDs/PIs: More than one PD/PI, or multiple PDs/PIs, may be designated on the
application. Number of
Applications: Applicants may submit more than one application,
provided they propose scientifically distinct conferences or scientific
meetings. Resubmissions: Applicants may submit a resubmission application, but such
application must include an “Introduction” (limited to one page) addressing
the previous peer review critique (Summary Statement). Renewals. Applicants
Materials: See Section IV.1 for application materials. General Information. For general information on SF424 (R&R) Application and
Electronic Submission, see these the following Web sites: SF424 (R&R)
Application and Electronic Submission Information: http://grants.nih.gov/grants/funding/424/index.htm; General information
on Electronic Submission of Grant Applications: http://era.nih.gov/ElectronicReceipt/. Hearing Impaired. HHS/CDC Telecommunications for the hearing impaired is available at
the following number: TTY 770-488-2783. Table of
Contents Part I Overview
Section I. Funding Opportunity Description 1. Research Objectives Section II. Award Information 1. Mechanism of Support 2. Funds Available Section III. Eligibility Information 1. Eligible Applicants A. Eligible
Institutions B.
Eligible Individuals 2.Cost Sharing or Matching
3.Other - Special
Eligibility Criteria Section IV. Application and Submission
Information 1.
Request Application Information 2. Content and Form of Application Submission 3. Submission Dates and Times
Receipt and Review and Anticipated Start Dates
1. Letter of Intent B. Submitting
an Application Electronically
C. Application Processing 4. Intergovernmental Review
Other Submission Requirements Section V. Application Review Information 1.
Criteria 2. Review and Selection
Review Criteria B. Additional
Review Considerations C. Sharing
Research Data D. Sharing
Research Resources 3. Anticipated Announcement
and Award Dates Section VI. Award Administration Information 1. Award Notices 2.
Administrative and National Policy Requirements 3.
Reporting Section VII. Agency Contact(s) 1. Scientific/Research
Contact(s) 2. Peer Review Contact(s) 3. Financial/ Grants
Management Contact(s) 4. General Questions
Contact(s) Section VIII. Other Information - Required Federal Citations
NIOSH recognizes the value of supporting high
quality scientific meetings that are relevant to its scientific mission and to
the public health. A scientific meeting is defined as a gathering, symposium,
seminar, conference, workshop or any other organized, formal meeting where
persons assemble to coordinate, exchange, and disseminate information or to
explore or clarify a defined subject, problem, or area of knowledge. Support of
such meetings is contingent on fiscal and programmatic interests and priorities
of NIOSH (see http://www.cdc.gov/niosh/ and http://www.cdc.gov/niosh/programs/. While training is often a part of conferences
or scientific meetings, applications for training only events will not be
considered under this announcement.
This FOA will use the Scientific Conference/Meeting
(R13) grant award mechanism. Under the R13 mechanism, the applicant will be
Multiple year awards may be made to a permanently sponsoring organization for
conferences held annually on a recurring topic. The total project period for an
application requesting support may not exceed three years.
This funding opportunity uses just-in-time
concepts (see SF424
Applicants must complete and submit a
detailed categorical request using the Research & Related Budget component.
Because the nature and scope of the proposed
size and duration of each award will also vary. Although the NIOSH financial
plans provide support for this program, awards pursuant to this funding
opportunity are contingent upon the availability of funds. Awards may range up to $20,000 (total costs). Applicants
requesting more than $20,000 (total costs) must obtain written prior approval
from the NIOSH Scientific Program Official assigned to this announcement. If an
applicant requests a funding amount greater than the ceiling of the award range
without providing the required letter of approval from NIOSH, the application will
be considered non-responsive, and it will not enter into the review process.
HHS/CDC will notify the applicant that the application did not meet the
submission requirements. NOTE: the letter approving submission of an
application exceeding the $20,000 total costs limit does not assure funding. HHS
grants policies as described in both the HHS Grants Policy Statement, will
Eligible Applicants 1.A. Eligible Institutions
organizations/institutions are eligible to apply: Public nonprofit organizations
Small, minority, and women-owned businesses
Federally recognized or state-recognized American
Indian/Alaska Native tribal governments
American Indian/Alaska Native tribally designated
Alaska Native health corporations
Urban Indian health organizations
State and local governments or their Bona Fide Agents
(this includes the District of Columbia, the Commonwealth of Puerto Rico,
the Virgin Islands, the Commonwealth of the Northern Marianna Islands,
American Samoa, Guam, the Federated States of Micronesia, the Republic of
the Marshall Islands, and the Republic of Palau)
Political subdivision of States (in consultation with
Foreign institutions are
A Bona Fide Agent is an agency/organization identified by
the state as eligible to submit an application under the state eligibility in
lieu of a state application. If you are applying as a bona fide agent of
a state or local government, you must provide a letter from the state or local
government as documentation of your status. Include this document in the Research and Related Other
Project Information in section 11, Other Attachments.
institutions or organizations, including established scientific or professional
societies, are eligible to apply for conference support. Both domestic and
international conferences may be supported; however, an international
conference can be supported only through the U.S. representative organization
of an established international scientific or professional society. An
individual is not eligible to receive a grant in support of a conference.
Any individual(s) with the skills, knowledge,
and resources necessary to carry out the proposed research as the PD/PI is
individuals with disabilities are always encouraged to apply for support.
More than one PD/PI, or multiple PDs/PIs, may
be designated on the application for projects that require a “team science”
approach and therefore clearly do not fit the single-PD/PI model. Additional
allow more than one PD/PI on individual research projects is available at http://grants.nih.gov/grants/multi_pi. All PDs/PIs must be registered in the NIH eRA
The decision of whether to apply for a single
PD/PI or multiple PD/PI grant is the responsibility of the investigators and
project. Applications for multiple PD/PI grants will require additional
2. Cost Sharing or Matching This program does not require cost sharing as
defined in the current HHS Grants Policy Statement.
Conference grant applications are reviewed
three times per year (Feb/June/Oct). NIOSH will only accept applications with
at least an eight-month span of time between a standard application submission
date (April/Aug/Dec) and the date of the scientific meeting. Interested
applicants should refer to the respective Standard Submission Dates and Earliest
Meeting Dates listed below:
Standard Submission Date
Earliest Meeting Date
December 12 of same year
April 12 of following year
August 12 of following year
Number of Applications. Applicants may submit more than one application, provided each
application is scientifically distinct. Resubmissions. Applicants may submit a resubmission application, but such application
(Summary Statement). Renewals. Applicants may submit a renewal application.
Package and SF424 (R&R) Application Instructions for completing the SF424
(R&R) forms for this FOA, link to Grants.gov/Apply and follow the directions provided on that Web site.
whether their organization/institution is already registered with both Grants.gov and the Commons. All registrations must be complete by
the submission deadline for the application to be considered “on-time” (see
A one-time registration is required for
institutions/organizations at the following:
Grants.gov Get
Registered, http://www.grants.gov/applicants/get_registered.jsp eRA Commons Prepare
to Apply, http://era.nih.gov/ElectronicReceipt/preparing.htm PD/PIs should work with their
institutions/organizations to make sure they are registered in the eRA Commons. The following steps are required before an
applicant institution/organization can submit an electronic application:
1) Organizational/Institutional Registration in Grants.gov/Get
will need to obtain a Data
(CCR) as part of the Grants.gov registration process. If your organization
does not have a Taxpayer Identification Number (TIN) or Employer Identification
Number (EIN), allow for extra time. A valid TIN or EIN is necessary for
CCR registration. The CCR also validates the EIN against Internal
To find out if an
organization is already eRA Commons-registered, see the "List
of Grantee Organizations Registered in NIH eRA Commons.” Direct questions
regarding the eRA Commons registration to: eRA Commons Help Desk
Email commons@od.nih.gov 3) Project Director/Principal Investigator (PD/PI) Registration in the eRA
Commons: Refer to the NIH eRA
Commons System (COM) Users Guide.
The individual(s) designated as PDs/PIs on the application
must be registered also in the NIH eRA Commons. In the case of multiple
PDs/PIs, all PDs/PIs must be registered and be assigned
the PI role in the eRA Commons prior to the submission of the application. Each
PD/PI must hold a PD/PI account in the Commons. Applicants should not share a
Commons account for both an Authorized Organization Representative/Signing
Official (AOR/SO) role and a PD/PI role; however, if they have both a PD/PI
role and an Internet Assisted Review (IAR) role, both roles should exist under
one Commons account. When multiple
with their own organization to be able to access the Commons. This
already registered in the Commons. Both the PD(s)/PI(s) and
to view the application image. Note: The registration
and the SF424 (R&R) forms. 1.
Note: Only the forms package directly attached
to a specific FOA can be used. You will not be able to use any other SF424
(R&R) forms (e.g., sample forms, forms from another FOA); although some of
the "Attachment" files may be useable for more than one FOA.
For further assistance within www.grants.gov, please
contact support@grants.gov.
For further assistance, contact GrantsInfo: Telephone 301-435-0714, Email: GrantsInfo@nih.gov.
TTY 770-488-2783.
Content and Form of Application Submission Prepare all applications using the SF424 (R&R) application forms for this
FOA through Grants.gov/Apply in accordance with the SF424 (R&R) Application Guide.
“Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications.” The SF424 (R&R) application has several components.
with this FOA in Grants.gov/APPLY includes all applicable components, required and
optional. A completed application in response to this FOA includes the data in
the following components: Required Components: SF424 (R&R) (Cover component) Research & Related Project/Performance
Information Research & Related Senior/Key Person PHS398 Cover Page Supplement PHS398 Research Plan PHS398 Checklist
Optional Components: PHS398 Cover Letter File Research & Related Sub award Budget Attachment(s)
multiple PDs/PIs are proposed, HHS/CDC requires one PD/PI to be designated as
the "Contact” PI, who will be responsible for all communication between
the PDs/PIs and the HHS/CDC, for assembling the application materials outlined
below, and for coordinating progress reports for the project. The contact PD/PI
must meet all eligibility requirements for PD/PI status in the same way as
other PDs/PIs, but has no other special roles or responsibilities within the
project team beyond those mentioned above. Information
for the Contact PD/PI should be entered on the SF424 (R&R) Cover
Multiple PD/PI Leadership Plan: For
applications designating multiple PDs/PIs, the section of the Research Plan,
When multiple institutions are involved, one
institution must be designated as the prime institution and funding for the
instruction regarding the use of the subaward budget form. 3. Submission
See Section IV.3.A for details
Submission, Review and Anticipated Start Dates Opening Date: September 25, 2010 (Earliest date an application may be submitted
For details, please see http://grants.nih.gov/grants/funding/submissionschedule.htm. Peer Review Date(s): Standard dates apply, please see (http://grants.nih.gov/grants/funding/submissionschedule.htm)
Council Review Date(s): Standard dates apply, please see (http://grants.nih.gov/grants/funding/submissionschedule.htm)
Earliest Anticipated Start Date: Standard dates apply, please see (http://grants.nih.gov/grants/funding/submissionschedule.htm)
letter of intent that includes the following information:
Descriptive title of
proposed conference or scientific meeting.
telephone number of the Principal Investigator Names of other key
personnel Participating
institutions Number and title of
this funding opportunity Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent
application, the information that it contains allows NIOSH Review staff to
Lee Sanderson, Ph.D.
Scientific Program Official
1600 Clifton Road NE, Mailstop E74
Atlanta, GA 30333 Phone: 404-498-2546
Fax: 404-498-2571 e-mail: LSanderson@cdc.gov and copy OEP Correspondence
(CDC)@cdc.gov Overnight Mail Address:
2400 Century Parkway NE (4th Floor)
Submitting an Application Electronically
To submit an application in response to this FOA,
applicants should access this FOA via http://www.grants.gov/applicants/apply_for_grants.jsp and follow Steps 1-4. Note: Applications must only be
submitted electronically. PAPER APPLICATIONS WILL NOT BE ACCEPTED. All attachments must be provided
Submitting On-Time Applications may be submitted on or
no later than 5:00 p.m. local time (of the applicant institution/organization) on the application submission/receipt date(s). (See Section IV.3.A. for all dates.) If an application is not submitted by the receipt date(s) and time, the
registrations must be complete prior to the submission deadline.
for errors and warnings and view their assembled application! 3.C.2 Two
Day Window to Correct eRA Identified Errors/Warnings
submitted through Grants.gov, NIH (who receives applications on behalf of
NIOSH) provides applicants a two day error correction window to correct any eRA
identified errors or warnings before a final assembled application
is created in the eRA Commons. The standard error correction window is two (2)
business days, beginning the day after the submission deadline and excluding
weekends and standard federal holidays. All errors must be corrected to
successfully complete the submission process. Warnings will not prevent the
application from completing the submission process.
Please note that the following caveats
of “on-time” submission (e.g., Grants.gov timestamp and tracking number) and
weekdays (Monday – Friday, excluding Federal holidays) to view the assembled
application before
it automatically moves forward to NIH for further processing. If everything is
acceptable, no further action is necessary. The application will
submit a Changed/Corrected application. In these
cases, please contact the eRA Help Desk to ensure that the issues are
addressed and corrected. Once rejected, applicants should follow the
applications. The “Reject” feature should also be used if you
determine that warnings are applicable to your application and need to be
addressed now. Remember, warnings do not stop further application
processing. If an application submission results in warnings (but no
errors), it will automatically move forward after two weekdays if no action
is taken. Some warnings may need to be addressed later in the process.
If the two day
option to “Reject” the application if, due to an eRA Commons or Grants.gov
contact the eRA
Commons Helpdesk to confirm the
system error, document the issue, and determine the best course of action.
NIH will not penalize the applicant for an eRA Commons or Grants.gov
system issue. If the AOR/SO
subject to the NIH late policy guidelines and may not be accepted. The reason for this delay
should be explained in the cover letter attachment. Both the AOR/SO and
PD/PI will receive e-mail notifications when the application is rejected
or the application automatically moves forward in the process after two
days. Upon receipt, applications will be evaluated
for completeness by the Center for Scientific Review, NIH. Incomplete
There will be an acknowledgement of receipt of
applications from Grants.gov and the Commons. The
submitting AOR receives the Grants.gov acknowledgments. The AOR and the PI
receive Commons acknowledgments. Information related to the assignment of an
application to a Scientific Review Group is also in the Commons. Note: Since email can be unreliable, it is the
NIOSH will not accept any application in
response to this FOA that is essentially the same as one currently pending
initial merit review unless the applicant withdraws the pending application. NIOSH
will not accept any application that is essentially the same as one already
reviewed. However, NIOSH will accept a resubmission application, but such
application must include an Introduction addressing the critique from the
previous review. 4.
Intergovernmental Review Executive
Order 12372 does not apply to this program.
5. Funding Restrictions All CDC/NIOSH awards are subject to the terms
and conditions, cost principles, and other considerations described in the HHS Grants Policy Statement.
Allowable Costs: Salaries in proportion to the time or effort spent directly
on the meeting; rental of necessary equipment; travel and per diem or
subsistence allowances; supplies needed for conduct of the meeting, only
if received for use during the budget period; conference services;
publication costs; registration fees; speakers' fees.
Non-allowable Costs: Purchase of equipment; transportation costs exceeding coach
class fares; visas; passports; entertainment; tips; bar charges; personal
telephone calls; laundry charges; organization dues; honoraria or other
payments for the purpose of conferring distinction or communicating
respect, esteem or admiration; patient care; alterations or renovations;
facilities and administrative costs. Pre-award costs are not allowed. 6. Other
Submission Requirements Applications with total costs exceeding $20,000 need advance approval from
NIOSH. Such approval should be requested early in the process, and no later
than two months before the receipt date. The letter from NIOSH documenting
advance approval to request more than $20,000 (total costs) must be submitted
with the application. Attach the letter as part of the PHS 398 Cover Letter
component (PDF). If an application is received without an approval letter, it
will not be accepted for review. Note that advance approval to submit an
application does not guarantee funding. Resubmission and renewal applications
will be accepted. The following instructions are to be used in conjunction with the
SF424 (R&R) Application Guide accompanying the SF424 (R&R) application
SF424 (R&R) Cover Component: Enter the title of the
scientific conference or scientific meeting in the
Descriptive Title of Applicant’s Project field of the SF424 Cover component.
Research and Related Project/Performance Site Locations: Enter the
site of the conference or meeting as the Performance Site. Research and Related Budget: The NIOSH conference award
contact should be consulted for guidance regarding any NIOSH specific budget
requirements. Enter the direct costs requested. Provide a narrative
justification for each proposed personnel position, including role and proposed
level of effort. Include information regarding efforts to obtain funding for
this conference/meeting from other sources. If the proposed conference is one
of an ongoing series, please include a justification for why
NIOSH support is required to continue the series, in addition to registration
fees and/or other sources of support. PHS 398 Checklist Component: The checklist is required;
however, no information regarding facilities and administrative (F&A) costs
(also called indirect costs) should be included as these are not allowable
costs for this mechanism
requires the PD(s)/PI(s) to fill in his/her Commons User ID in the “PROFILE –
The applicant organization must include its DUNS number
in its Organization Profile in the eRA Commons. This DUNS number must match the
DUNS number provided at CCR registration with Grants.gov. For additional information, see
“Frequently Asked Questions – Application Guide, Electronic Submission
to be followed, incorporating "Just-in-Time"
(required for a resubmission or revision application) is limited to 1
page. Research
Strategy, including tables, graphs, figures, diagrams, and charts, is
limited to 6 pages. Note that this section will be called “Research
Strategy” in the system-generated Table of Contents. Do not complete
the Human Subjects sections of the PHS 398 Research Plan.
Aims is required on the PHS 398
Research Plan and limited to one page
In the “Conference Plan” section of the
application (uploaded as the Research Strategy attachment), describe
the objectives, specific program, and logistical arrangements for the meeting.
Describe the format and list the agenda and speakers, including the principal
topics to be covered, problems to be addressed, and developments or
contributions the conference/meeting might stimulate. Provide a detailed
justification for the conference/meeting, including the scientific need,
timeliness, and usefulness of the conference/meeting to the scientific
community. Describe the composition and role of the organizing committee, and
provide the names and credentials of key participants in the
conference/meeting, including the basis for their selection and documentation
of their agreement to participate.
Describe plans for the appropriate involvement of women, minorities,
and persons with disabilities in the planning and implementation of, and
participation in, the proposed conference/meeting. Describe
plans to identify resources for child care and other types of family care at
the conference site to allow individuals with family care responsibilities to
attend. That information should allow attendees to make arrangements for family
care as needed. Estimate the expected size and composition of the audience, as
well as the method of selection. Describe plans for publicizing the
conference/meeting to all interested participants and for publishing the
proceedings (with the latter possibility not being required). Identify related conferences
or meetings held on the subject during the past 3 years and how the proposed
conference or meeting is similar to, and/or different from these, and why it is
still necessary and useful. If this is one of a series of periodic
conferences/meetings held by a permanent sponsoring organization, briefly
describe and evaluate the last conference/meeting in the series.
Applications requesting multiple years of support must provide the
following additional information for each future year requested, in as much
detail as possible: meeting topic(s); tentative dates, locations, and
participants; and contingency plans for future meetings dependent upon, for
example, the outcome of the first year’s conference/meeting or developments in
the field. A critical part of the application for CDC/NIOSH support of
conferences/meetings is documentation of appropriate representation of women,
racial/ethnic minorities, persons with disabilities, and other individuals who
have been traditionally underrepresented in science. Attendance
for some individuals will be dependent on the availability of resources for
family care. A broad cross section of individuals must be included in all
aspects of planning, organization, and implementation of CDC/NIOSH-sponsored
and/or supported conferences/meetings. “Appropriate representation” means
representation based on the availability of these scientists from these groups
known to be working in a particular field of biomedical or behavioral research.
If appropriate representation is not apparent, no award will be issued until
program staff members are assured of concerted recruitment efforts. Organizers
of scientific conferences/meetings must document compliance with the Guidelines
for Inclusion of Women, Minorities, and Persons with Disabilities in Scientific
Meetings Supported by the CDC/NIOSH. Appendix Materials The
appendix is limited to announcements and reports of previous
conferences/meetings under the same sponsorship. No other information or
material should be submitted as appendices.
Sharing Plan(s) The following resource sharing policies do
not apply to this FOA: Data Sharing Plan. Not Applicable Section V. Application Review Information
appropriate scientific review group in accordance with CDC/NIOSH peer review
procedures using the review criteria stated below. As part of the initial merit review, all
applications will:
process in which all applications will be discussed and assigned an impact/priority
score Receive a written
critique; and Receive a second
level of review by the NIOSH Secondary Review Committee
The mission of CDC/NIOSH is to
promote health and quality of life by preventing and controlling disease,
injury, and disability. The
goal of the NIOSH research and training programs is to identify the risks and
conditions that are associated with occupational diseases and injuries, to
explore methods for reducing risks and for preventing or minimizing exposure to
hazardous conditions in the workplace, and to translate significant scientific
findings into prevention practices and products that will effectively reduce
work-related illnesses and injuries. The scientific review group will address
and consider each of the review criteria in assigning the application's overall
score, weighting them as appropriate for each application.
Reviewers will provide an overall impact/priority
consideration of the following five scored review criteria, and additional
review criteria (as applicable for the project proposed). Scored Review Criteria
Reviewers will consider each of the five
and give a separate score for each. An application does not need to be strong
in all categories to be judged likely to have major scientific impact. For
Significance. Does the conference/scientific
meeting address an important problem or a critical barrier to progress in the
knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the conference/scientific meeting change the
Investigator(s). Are the PDs/PIs, collaborators, and other researchers well suited for
organizing and fulfilling the goals of this conference/scientific
meeting? If Early Stage Investigators or New Investigators, or in the
structure appropriate for the project? Are the key personnel and selected
speakers appropriate and well suited for their described roles in the
conference/scientific meeting?
the conference/scientific meeting content challenge and seek to shift current
research or clinical practice paradigms, or employ novel approaches or methods
to fulfill its purpose? Will the conference/scientific meeting cover
to one field of research or novel in a broad sense? Will the
conference/scientific meeting address a refinement, improvement, or new
instrumentation, or interventions proposed? Does the conference/scientific
meeting draw together appropriate experts who may otherwise not have an
opportunity to meet?
Approach. Are
the format and agenda for the conference/meeting well-reasoned and appropriate
to accomplish the specific aims of the conference/scientific meeting? Are
presented? If the field is in the early stages of development, will the
conference/scientific meeting establish feasibility and will particularly risky
aspects be addressed? If the project involves clinical research, are the plans for 1) protection of
of the scientific goals and research strategy proposed? Is the
conference/meeting timely for the subject matter?
the conference/scientific meeting site contribute to the probability of
resources available adequate for the conference/meeting proposed? Will
the conference/scientific meeting benefit from unique features of the
arrangements? Additional Review
As applicable for the project proposed,
reviewers will consider the following additional
for Human Subjects. For research that involves human subjects but does not involve one
committee will evaluate the justification for involvement of human subjects and
the proposed protections from research risk relating to their participation
others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring
of Women, Minorities, and Children. When the proposed project involves clinical
Biohazards. Reviewers will
assess whether materials or procedures proposed are potentially hazardous to
research personnel and/or the environment, and if needed, determine whether
Appropriate Representation: How well do the plans for inclusion of women, racial/ethnic minorities, persons
with disabilities, and other individuals who traditionally have
been underrepresented in science provide for their appropriate
representation in the planning, organization, and execution of the proposed
conference/scientific meeting? Resubmission Applications. When reviewing a Resubmission application (formerly called an amended
committee will consider whether the responses to comments from the previous scientific
review group are adequate and whether substantial changes are clearly evident. Additional Review Considerations
As applicable for the project proposed, reviewers will address each of the
proposed research may be assessed by the reviewers. Selection Process
(written critique) via the eRA Commons. If
the application is under consideration for funding, NIOSH will request
"just-in-time" information from the applicant. HHS grants policies as
described in the HHS Grants
Policy Statement will apply to the applications submitted and awards made
A formal notification in the form of a Notice
of Award (NoA) will be provided to the applicant organization. The NoA signed
by the Grants Management Officer (GMO) is the authorizing document. CDC will
mail and/or e-mail this document to the recipient fiscal officer identified in
the application. Selection of the application for award is not
an authorization to begin performance. Any cost incurred before receipt of the
NoA is at the recipient’s risk. These costs may be reimbursed only to the
extent considered allowable pre-award costs. See also Section IV.5. Funding Restrictions.
All CDC/NIOSH grant and cooperative agreement awards
include the HHS Grants Policy Statement as part of the
NoA.The following Terms and Conditions will be
of award. All conference material (promotional
materials, agenda, publications an internet sites) related to this project must
include an acknowledgement of NIH grant support and a disclaimer stating the
following: “Funding for this conference was made possible [in part] by
[insert grant number] from NIOSH. The views expressed in written
Services; nor does mention of trade names, commercial practices, or organizations
imply endorsement by the U.S. Government.”
3. Reporting Recipient organizations must provide CDC/NIOSH with an original, plus
two hard copies of the following reports:
1) Non-Competing Grant Progress
Report, (use form PHS 2590, posted on the CDC/NIOSH website, and at , no less than 120 days prior to the end of the current
application. The Progress Report should include a report of the previous
meeting supported by the current grant, as well as a full description of the
next planned meeting.
2) Financial status report, no more
than 90 days after the end of the budget period.
3) Final financial and performance
reports, no more than 90 days after the end of the project period.
plans of NIOSH provide support for this program, awards pursuant to this
funding opportunity are contingent upon the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required reports) and
the determination that continued funding is in the best interest of the Federal
Section VII. Agency Contacts CDC/NIOSH encourages
your inquiries concerning this FOA and welcomes the opportunity to answer
questions from potential applicants. Inquiries can fall into three areas: scientific/research,
peer review, and financial or grants management issues: 1. Scientific/Research Contacts: Steven Inserra, MPH
Atlanta, GA 30333 Phone: 404-498-2552
Fax: 404-498-2571 e-mail:SInserra@cdc.gov and copy OEP Correspondence (CDC)@cdc.gov Overnight Mail Address:
2. Peer Review Contacts: Price Connor, Ph.D. Scientific Review Officer
Telephone: (404) 498-2511
FAX: (404) 498-2571 Email: PConnor@cdc.gov Overnight Mail Address:
2400 Century Parkway NE (4th Floor) Atlanta GA 30345-3114
3. Financial or Grants Management Contacts: Peter Grandillo Jr. Acquisition and Assistance Field Branch
FAX: (412) 386- 6429
4. General Questions Contacts: Technical Information Management Section
Federal Citations Human
Federal regulations (45 CFR Part 46) require that
and the importance of the knowledge gained or to be gained (http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm). Additional HHS/CDC
Use of Animals in Research Recipients of PHS support for activities involving
live, vertebrate animals must comply with the PHS Policy on Humane Care and Use
of Laboratory Animals (http://grants.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf) as mandated by the Health
the policy of the Centers for Disease Control and Prevention (CDC) and the
Agency for Toxic Substances and Disease Registry (ATSDR) to ensure that
individuals of both sexes and the various racial and ethnic groups will be
included in CDC/ATSDR-supported research projects involving human subjects,
whenever feasible and appropriate. Racial and ethnic groups are those defined
in OMB Directive No. 15 and include American Indian or Alaska Native, Asian,
Black or African American, Hispanic or Latino, Native Hawaiian or Other Pacific
The policy of CDC is that persons under the age of 21 must be included in all
human subjects research that is conducted or supported by CDC, unless there are
of 45 CFR Part
46, HHS Policy for the Protection of Human Subjects. Therefore, proposals
a specific age range, or an explanation of the reason(s) for excluding persons under
the age of 21 as participants in the research. When persons under the age of 21
are included, the plan must also include a description of the expertise of the
investigative team for dealing with individuals at the ages included, the
appropriateness of the available facilities to accommodate the included age
research must be in compliance with all applicable subparts of 45 CFR Part
provisions to protect data collected through HIV/AIDS surveillance, including copies
of local data release policies; employee training in confidentiality
provisions; State laws, rules, or regulations pertaining to the protection or
release of surveillance information; and physical security of hard copies and
electronic files containing confidential surveillance information.
the requirements for a program review panel, you are encouraged to use an
This program is subject to the Public Health System
Reporting Requirements. Under these requirements, all community-based
non-governmental organizations submitting health services applications must
prepare and submit the items identified below to the head of the appropriate
State and/or local health agency(s) in the program area(s) that may be impacted
by the proposed project no later than the application deadline date of the
Federal application. The appropriate State and/or local health agency is
determined by the applicant. The following information must be provided:
A. A copy of the face page of the application (SF 424). B. A summary of the project that should be titled "Public Health
System Impact Statement" (PHSIS), not exceed one page, and include the
description of the population to be served.
summary of the services to be provided.
description of the coordination plans with the appropriate state and/or local
If the State and/or local health official should desire
a copy of the entire application, it may be obtained from the State Single
Point of Contact (SPOC) or directly from the applicant.
HHS/CDC strongly encourages all recipients to provide a
smoke-free workplace and to promote abstinence from all tobacco products.
Potential applicants may obtain a copy of "Healthy People 2010" at www.healthypeople.gov.
need to be careful to prevent HHS/CDC funds from being used to influence or
campaigns intended or designed to influence members of Congress with regard to
specific legislation or appropriation by Congress.
Act, HHS/CDC interprets the language in the HHS/CDC's Appropriations Act to
mean that HHS/CDC's funds may not be spent on political action or other
activities designed to affect the passage of specific Federal, State, or local
legislation intended to restrict or control the purchase or use of firearms.
It may be necessary to conduct an on-site evaluation of
some applicant organization's financial management capabilities prior to or
nonprofit organizations with the application. Any of the following is
acceptable evidence of nonprofit status: (a) a reference to the applicant organization's
grant or cooperative agreement in a HHS/CDC-owned or leased facility (on-site
facility) must receive a favorable security clearance, and meet all security
The signature of the institution official on
the face page of the application submitted under this Funding Opportunity
Announcement is certifying compliance with the Department of Health and Human
Services (DHHS) regulations in Title 42 Part 93, Subparts A-E, entitled PUBLIC
HEALTH SERVICE POLICIES ON RESEARCH MISCONDUCT.
further guidance on the use of DHHS direct financial assistance see Title 45,
Code of Federal Regulations, Part 87, Equal Treatment for Faith-Based
public health authority for the purposes of this project. Release and Sharing of Data
a timely manner. b. Completely,
and as accurately as possible. c. To
facilitate the broader community. d. Developed
in accordance with HHS/CDC policy on Releasing and Sharing Data. April 16, 2003, http://www.cdc.gov/od/foia/policies/sharing.htm, and in full compliance with
the 1996 Health Insurance Portability and Accountability Act (HIPPA), (where
applicable), The Office of Management and Budget Circular A110, (2000) revised
2003, www.whitehouse.gov/omb/query.html?col=omb&qt=Releasing+and+Sharing+of+Data and Freedom of
Information Act (FOIA) http://www.cdc.gov/od/foia/index.htm.
Applications must
include a copy of the applicant's Data Release Plan. Applicants should provide
HHS/CDC with appropriate documentation on the reliability of the data.
Applications submitted without the required Plan may be ineligible for award.
Award will be made when reviewing officials have approved an acceptable Plan.
The successful applicant and the Program Manager will determine the
documentation format. HHS/CDC recommends data is released in the form closest
to micro data and one that will preserve confidentiality. National Historic Preservation Act of 1966
a. Section 106 of the National Historic Preservation
Act (NHPA) states:
organizations imply endorsement by the U.S. Government.” Logos: Neither the HHS nor the CDC (“CDC” includes
source of the conference or give the false appearance of Government
endorsement. A non-federal entity’s unauthorized use of the HHS name or logo is
governed by U.S.C. § 1320b-10, which prohibits the misuse of the HHS name and
emblem in written communication. The appropriate use of the HHS logo is subject
to the review and approval of the Office of the Assistant Secretary for Public
Affairs (OASPA). Moreover, the Office of the Inspector General has authority to
impose civil monetary penalties for violations (42 C.F.R. Part 1003). Neither
the HHS nor the CDC logo can be used on conference materials under a grant,
cooperative agreement, contract or co-sponsorship agreement without the
expressed, written consent of either the Project Officer or the Grants
Management Officer. It is the responsibility of the grantee (or recipient of
funds under a cooperative agreement) to request consent for the use of the logo
in sufficient detail to assure a complete depiction and disclosure of all uses
of the Government logos, and to assure that in all cases of the use of
Government logos, the written consent of either the Project Officer or the
Grants Management Officer has been received.